High Quality Stigmast-5-en-3-ol, (3b) CAS NO.83-46-5
- FOB Price: USD: 1.00-1.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,
- Available Specifications:
1(1-2)Gram
- Product Details
Keywords
- 83-46-5
- Stigmast-5-en-3-ol, (3b)
- Stigmast-5-en-3-ol, (3b) Price
Quick Details
- ProName: High Quality Stigmast-5-en-3-ol, (3b)
- CasNo: 83-46-5
- Molecular Formula: C29H50O
- Appearance: White powder
- Application: pharmaceutical intermediates
- DeliveryTime: Qingdao Port
- PackAge: 1kg or 25Kg drum
- Port: QIngdao Port
- ProductionCapacity: 3000 Metric Ton/Year
- Purity: 98% HPLC
- Storage: Store in dry, dark and ventilated plac...
- Transportation: By air or by sea. Prompt delivery
- LimitNum: 1 Gram
- Moisture Content: See data sheet
- Samples: Available
Superiority
We promise our customer following items
1.Reasonable price:
2.Low moq:No worry about the low moq, our moq is 1 gram or lower.
3.Good and efficient service,Fast Delivery
4.Super-good quality
Details
Product name:Beta Sitosterol
Molecular Formula: C29H50O
Molecular Weight: 414.71
CAS Number: 83-46-5
EINECS: 201-480-6
Beta-Sitosterol is one of several phytosterols with chemical structures similar to that of cholesterol. Beta-Sitosterol is white in colour and waxy in nature. Beta-Sitosterol is widely distributed in the plant kingdom and found in black cumin seed[1]Nigella Sativa, pecans, Serenoa repens (saw palmetto), avocados, Curcurbita pepo (pumpkin seed), Pygeum africanum, cashew fruit, rice bran, wheat germ, corn oils, soybeans, sea-buckthorn and wolfberries.
Alone and in combination with similar phytosterols, β-sitosterol reduces blood levels of cholesterol, and is sometimes used in treating hypercholesterolemia. One small study shows a positive effect on male hair loss in combination with Saw palmetto.In Europe, β-sitosterol plays a major role in treatment of herbal therapy of benign prostatic hypertrophy (BPH). Beta-Sitosterol is also used in Europe for the treatment of prostatic carcinoma and breast cancer, although the benefits are still being evaluated in the US.